Connexus Biotech AB
ActiveKey figures
Key figures
2025Summary: Connexus Biotech AB
What kind of company is it?
Connexus Biotech AB (org. no. 559180-9255) is a limited company (AB). The company was registered in 2018 and has existed for 7 years. Registered seat: Vellinge. Industry according to Statistics Sweden: industrial engineering activities and related technical consultancy (SNI 71122).
How is the company doing financially?
Net sales in financial year 2025 were 872 410 kr, down 7,9 % on the previous year (946 956 kr). Net profit for 2025 was 382 027 kr (43,8 % of net sales). At the end of financial year 2025, total assets were 1 466 943 kr and equity 827 738 kr (equity ratio 56,4 %). The annual report for 2025 proposes a dividend of 220 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-09. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 220 000 kr.
Summary of annual reports2024–2025
| 2024 | 2025 | |
|---|---|---|
| Sales revenue | 946 956 | 872 410 |
| Profit for the reporting year | 531 697 | 382 027 |
| Retained earnings of previous periods | — | — |
| Total assets | 1 376 056 | 1 466 943 |
| Total liabilities | 730 344 | 639 205 |
| Total equity | 645 712 | 827 738 |
| Employees | — | — |
| Proposed dividend | — | 220 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.